This review article will introduce some of the small molecule drugs that are currently receiving significant attention: Orforglipron Orforglipron is an oral small molecule GLP-1RA developed jointly by Eli Lilly and Chia Tai Tianqing Pharmaceutical Group
8,9 GLP-1 agonists also upregulate keratinocyte migration due to P13K/Akt activation, which is pertinent to wound healing
Accessed 5/7/2024, Hinnen D, Kruger D, Magwire M
The evidence remains early, but it is strong enough to guide thoughtful, real-world use
Chromium supplementation is often followed by improved blood sugar control - and it may also aid in weight management and reducing cravings especially for carbohydrates
A 100% vegetable origin, biodegradable, mild cleansing agent that gives moderate to high amount of foam